Therapeutic use of d-methionine to reduce the toxicity of platinum-containing anti-tumor compounds
CA 2265983 C · Owner: The Board Of Trustees Of Southern Illinois University · Inventors: Campbell, Kathleen C. M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of preventing or reducing hearing or balance loss damage to ear , cells, weight loss, gastrointestinal toxicity neurotoxicity, alopecia, and , prolonging survival in patients undergoing treatment with therapeutically effective amounts of platinum-containing chemotherapeutic agents such as cisplatin are provided. These methods comprise administering an effective amount of a methionine protective agent such as D-methionine, prior to, simultaneously with or subsequently to administration of the platinumcontaining chemotherapeutic agent. Combinations of these time periods can also be employed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 2, 1997 and granted December 23, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 2, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 2, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.